Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11e0b3804795e21269a7769254b2ea32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53f790abf0e3b0ba1ccb401e6f907cee |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2016-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d807f61a34b3371c7d70d3678f3b1d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23707cff1b85d51437eb785bb20782d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4ff58c9fba4eb4269aa75bcba54747a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fc9f6b37a1c457f583e2f4485a845e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_408668ed04e5dccbacbb59c38b80c05a |
publicationDate |
2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2016135273-A1 |
titleOfInvention |
Processes for the diagnosis, prognosis and monitoring of the progression of chronic lymphoid leukaemia (cll) and/or of systemic lupus erythematosus (sle) using membrane stim 1 |
abstract |
The present invention relates to a process for the diagnosis of systemic lupus erythematosus (SLE) and/or of chronic lymphoid leukaemia (CLL) of a subject who may be suffering therefrom, comprising the in vitro detection of the expression of the fraction of the STIM1 protein located at the cell plasma membrane in a biological sample from human and mice. It also relates to a process for predicting the progression and/or monitoring the progression of CLL and/or of SLE, comprising the in vitro detection of the expression of the fraction of the STIM1 protein located at the cell plasma membrane. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3714942-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3714943-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020193449-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020193451-A1 |
priorityDate |
2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |